Labshake search
Citations for R&D Systems :
451 - 500 of 3878 citations for Ciprofloxacin Hcl 100 Ug Ml In Methanol 2 3 Carboxyl 13C3 99%; Quinoline 15N 98% since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biochemistry 2022Quote: ... and supplemented with 100 ng/mL activin A (R&D Systems, Minneapolis, MN, USA) and 1% B27 minus insulin (Thermo Fisher Scientific) ...
-
Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson’s diseasebioRxiv - Neuroscience 2020Quote: ... 100 ng/ml recombinant human sonic hedgehog (SHH) (R&D systems, 464-SH-025CF), 2 μM purmorphamine (Reprocell ...
-
bioRxiv - Neuroscience 2022Quote: ... NLGN1 (Sino Biological, Cat. 11617-H08H-100, R&D Systems, Cat. AF4340, 50ng/mL), TSLP (Sino Biological ...
-
bioRxiv - Cell Biology 2019Quote: ... in the presence or not of IL-36RA (R&D Systems, 100 ng/ml) or Sunitinib (Pfizer S.r.l. ...
-
bioRxiv - Microbiology 2020Quote: ... followed by 4 days with 200ng/ml Noggin (R&D Systems, 6057-NG-100), 500ng/ml FGF4 (Peprotech ...
-
bioRxiv - Biophysics 2022Quote: ... the cells were treated with 20 – 100 U/ml IFN-γ (R&D Systems) and 1 μM TPI peptide (Genscript ...
-
bioRxiv - Immunology 2022Quote: ... the cells were treated with 20 – 100 U/ml IFN-γ (R&D Systems) and 1 μM TPI peptide (Genscript).
-
bioRxiv - Biophysics 2023Quote: ... and 100 ng/ml of recombinant mouse interferon-γ (IFN-γ, R&D Systems) (Farnsworth et al. ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 100 ng/mL of recombinant human IL-17B (R&D Systems, Minneapolis, MN) for 48 h and processed for downstream RNA expression analysis ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... penicillin-streptomycin) supplemented with 100 ng/mL EGF (R&D Systems, cat # 236-EG) and 100 ng/mL of BMP2 (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... and mouse epidermal growth factor (100 ng/ml) (R&D Systems, #2028-EG-200). Cells were plated in a six-well dish at a density of about 2 retinas per 10cm2 well ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/ml recombinant human M-CSF (R&D Systems 216-MC-100) at 37°C for seven days.
-
bioRxiv - Cell Biology 2024Quote: ... cells were stimulated with 100 ng/mL recombinant WNT3A (R&D Systems, 5036-WN) or WNT5A (R&D Systems ...
-
bioRxiv - Genomics 2024Quote: ... cells were also treated with or without TNFα (R&D systems, 100 ng/ml) at 48 h after transfection and harvested at 72 h after transfection (24 h after TNFα treatment).
-
bioRxiv - Microbiology 2023Quote: ... 100 µg/ml streptomycin and either 5 ng/ml granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D Systems, Abingdon, UK) to promote M1-differentiation or 20 ng/ml macrophage colony-stimulating factor (M-CSF ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of IL-2 (10 ng ml−1, R&D Systems), anti-IL-10 (50 μg ml−1 ...
-
bioRxiv - Microbiology 2021Quote: ... supplemented with 20 IU/mL rhIL-2 (R&D Systems Cat# 202-IL) for 72±4 hours at 37°C and 5% CO2 ...
-
bioRxiv - Microbiology 2021Quote: ... and cultured in media containing IL-2 (5 ng/ml; R&D Systems), in the presence or in the absence of GGSK2691805A (5 μM) ...
-
bioRxiv - Microbiology 2020Quote: ... and 2 ng/ml recombinant mouse TGF-β (R&D Systems, Minneapolis, MN).
-
bioRxiv - Immunology 2020Quote: ... anti-human IL-37 (2 μg/ml, goat polyclonal, R&D Systems, AF1975), anti-human caspase-1 p20 (1:1000 ...
-
bioRxiv - Immunology 2022Quote: ... alone or with mouse recombinant IL-2 (R&D Systems, 50 ng/ml) for 15 minutes at 37°C ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 20 ng/mL FGF-2 (R&D Systems, 233-FB-010), and 20 ng/mL PDGF-AA (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... and recombinant human IL-2 20 ng/ml (202-IL, R&D Systems). The QCM Leukocyte Migration Assay (MilliporeSigma ...
-
bioRxiv - Cell Biology 2023Quote: ... 50 ng/ml recombinant human Wnt3a (R&D Systems; day 1 and 2), 1 mM L-Glutamine (L-Glu ...
-
bioRxiv - Bioengineering 2024Quote: ... and 10 ng/ml fibroblast growth factor-2 (R&D Systems, Minneapolis, MN). For pellet cultures ...
-
bioRxiv - Immunology 2022Quote: ... cells were washed at day 7 and cultured at 0.5.106 cells/ml with 50 U/ml IL-2 (R&D Systems), 250 U/ml IFN-α (R&D Systems) ...
-
bioRxiv - Immunology 2022Quote: ... activated B cells were washed and cultured at 0.5.106 cells/ml with 50 U/ml IL-2 (R&D Systems), 5 ng/ml IL-4 (R&D Systems ...
-
bioRxiv - Cell Biology 2023Quote: ... A feeding layer of 2 ml RPMI growth medium supplemented with 10 ng/ml PDGF-BB ligand (R&D Systems) and/or 0.01 uM siRNA (see below ...
-
bioRxiv - Cell Biology 2019Quote: ... and expanded chondroprogenitor cells were re-suspended at 2.5 × 105 cells / mL in chondrogenic medium supplemented with 10 ng/ml human transforming growth factor beta 3 (TGF-β3; R&D Systems, Minneapolis, MN). Chondrogenic pellets were cultured at 37°C for 28 days ...
-
bioRxiv - Bioengineering 2024Quote: ... which was supplemented with 3 ng/mL human activin A (R&D Systems, Inc., Minneapolis, MN, USA), 1 ng/mL human bone morphogenetic protein 4 (Bmp4 ...
-
bioRxiv - Microbiology 2023Quote: ... ligand-loaded CD1d (0.25 ug per well) was bound onto Streptavidin-coated plates (R&D Systems #CP003). Plates were washed with PBS three times and then added 24.7 NKT cells (4 x 104∼105 per well ...
-
bioRxiv - Synthetic Biology 2021Quote: ... in a 1:1 ratio with 100 U mL-1 of IL-7 and 10U mL-1 IL-15 (R&D Systems) in tissue culture flasks ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with recombinant human IL-4 (50 ng/mL) and recombinant human GM-CSF (100 ng/mL) (R&D Systems, Minneapolis, MN) with one additional supplement of fresh media and cytokines at day 3 of culture as previously described 12 ...
-
bioRxiv - Immunology 2020Quote: ... and then re-suspended in 30 μL of media containing 10,000 units/mL of recombinant IFN-α2a or 100 units/mL of recombinant IFN-γ (R&D Systems). Antibodies against SiglecF ...
-
bioRxiv - Neuroscience 2023Quote: ... or bFGF (10 ng/mL) and diazepam (100 μM) (045-18901, Wako) or BMP4 (50 ng/mL) (5020-BP, R&D Systems) (quiescence medium ...
-
bioRxiv - Immunology 2019Quote: ... and homogenates were diluted to 2 mg/mL protein in PBS and were subsequently diluted 1:2 in Reagent Diluent (R&D Systems). CXCL10 protein was quantified using the Mouse CXCL10 Duoset ELISA kit (R&D Systems ...
-
bioRxiv - Bioengineering 2020Quote: ... supplemented with 1 ng/mL transforming growth factor beta-1 (TGF-β1) and 5 ng/mL fibroblast growth factor-2 (FGF-2) (both from R&D Systems) at 37°C and 5% CO2 in a humidified incubator (Thermo Scientific Heraeus ...
-
bioRxiv - Immunology 2022Quote: ... Frozen PBMC of post-CA patients were thawed and incubated in the media (RPMI1640 +2% FBS) with human anti-Nectin-2 monoclonal antibody or isotype control (20 μg/mL, both R&D Systems) for 6h ...
-
bioRxiv - Immunology 2021Quote: ... were measured by flow cytometry 2 days after activation with or without an extra stimulation with 25 ng/mL IL-2 (R&D Systems) during 15 min.
-
bioRxiv - Neuroscience 2021Quote: ... and 100 ng/ml murine recombinant fibroblast growth factor 8b (FGF-8b, R&D Systems) for 7 days in vitro (DIV) ...
-
bioRxiv - Neuroscience 2021Quote: ... the supplements in the medium were replaced with FGF8 (100 ng/ml; R&D Systems). From day 11 ...
-
bioRxiv - Genomics 2022Quote: ... 15140122) supplemented with final 100 ng/ml Activin-A (R&D Systems, 338-AC-01M) and 1,4 µg/ml CHIR99021 (Stemgent ...
-
bioRxiv - Bioengineering 2023Quote: ... iASCs were prepared by pretreating ASCs with interferon γ (100 ng/ml; R&D Systems) in ASC culture medium for 24 hours ...
-
bioRxiv - Genomics 2023Quote: ... (Thermo Fisher Scientific)] medium supplemented with recombinant human/mouse/rat activin A (100 ng/mL; R&D Systems) for 18 hours ...
-
bioRxiv - Cancer Biology 2023Quote: ... into 40 ml of R10 media supplemented with 10 ng/ml recombinant human IL-2 (R&D Systems, 202-IL-050). Cells were passaged twice per week and feeder cells were added in a 1:1 ratio after 7 days to maintain stimulation ...
-
bioRxiv - Immunology 2019Quote: ... then incubated overnight at 4°C in primary antibodies in 0.1% Triton X-100/PBS (rat anti-GP2, MBL, D278-3 at 1:500; sheep anti-SpiB, R&D Systems, AF7204 at 1:50 ...
-
bioRxiv - Neuroscience 2021Quote: ... Plates were washed 3 times with wash buffer and 100 ul of samples and standards were added (R&D Systems, UK). Plates were left to incubate at room temperature for 2 hours ...
-
bioRxiv - Cell Biology 2020Quote: ... during 2 hours and stimulated with human recombinant VEGF165 (25ng/ml, R&D System) during 30 minutes.
-
bioRxiv - Immunology 2019Quote: ... NK cells were activated for 72h in 300IU/ml rhIL-2 (R&D Systems). CD4 T cells were simultaneously activated and infected as described above ...
-
bioRxiv - Bioengineering 2020Quote: ... and recombinant human IL-2 (50 U/mL, R&D Systems, Minneapolis, MN, USA). Single cell suspensions were activated with 1 μg/ml Concavalin A (Sigma ...